| 1.705 -0.015 (-0.87%) | 12-19 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.11  |
1-year : | 2.26 |
| Resists | First : | 1.81 |
Second : | 1.94 |
| Pivot price | 1.79 |
|||
| Supports | First : | 1.61 | Second : | 1.33 |
| MAs | MA(5) : | 1.75 |
MA(20) : | 1.8 |
| MA(100) : | 1.75  |
MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 26.2 |
D(3) : | 34.3 |
| RSI | RSI(14): 41.7 |
|||
| 52-week | High : | 73.75 | Low : | 1.13 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ BON ] has closed above bottom band by 4.1%. Bollinger Bands are 42.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.76 - 1.78 | 1.78 - 1.79 |
| Low: | 1.67 - 1.69 | 1.69 - 1.7 |
| Close: | 1.68 - 1.71 | 1.71 - 1.72 |
Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. The company provides personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; natural health supplements comprising powder drinks and bioactive food ingredient products primarily used as food additives; and nutritional supplements. Its products are principally used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company was founded in 2006 and is headquartered in Grand Cayman, the Cayman Islands.
Wed, 10 Dec 2025
BON unveils kombucha-inspired product, signs $12 million sales deal - Investing.com
Wed, 10 Dec 2025
Bon Natural Life (Nasdaq: BON) signs $12M, 24-month Qingshengyuan sales pact - Stock Titan
Wed, 10 Dec 2025
Bon Natural Life Secures $12 Million Deal with Qingshengyuan for Kombucha Products - TipRanks
Tue, 25 Nov 2025
Bon Natural Life Enters $26M Agreement for Tea Pigment Products in China - TipRanks
Tue, 09 Sep 2025
80% More Bioactive: BON's Revolutionary Apple-Protein Blend Secures $18M China Distribution Deal - Stock Titan
Tue, 09 Sep 2025
BON’s New Discovery Sparks Stock Interest - timothysykes.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Packaged Foods
|
|
| Shares Out | 6 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 2 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 62 (K) |
| Shares Short P.Month | 14 (K) |
| EPS | 21.75 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 234.02 |
| Profit Margin | 2.6 % |
| Operating Margin | 3.5 % |
| Return on Assets (ttm) | 2.1 % |
| Return on Equity (ttm) | 1.1 % |
| Qtrly Rev. Growth | -21.9 % |
| Gross Profit (p.s.) | 0.99 |
| Sales Per Share | 3.54 |
| EBITDA (p.s.) | 0.51 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -10 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0.07 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0.48 |
| Price to Cash Flow | -1.03 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|